Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TAHOE: Sustained InTravitreal DexAmetHasone Implant (Ozurdex) for Uveitic Macular Edema

NCT01870440 is registered in ClinicalTrials.gov with Northern California Retina Vitreous Associates as lead sponsor.

NCT NCT01870440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01870440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TAHOE: Sustained InTravitreal DexAmetHasone Implant (Ozurdex) for Uveitic Macular Edema
Lead sponsor
Northern California Retina Vitreous Associates
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2013
Completion date
February 28, 2015
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular edema, uveitis